Physician profile
Mark E Brenner
NPI 1184631335
$19,538.31
in general payments reported to CMS, 2019-2025
33 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,293 · 2020: $2,090 · 2021: $2,721 · 2022: $1,358 · 2023: $4,267 · 2024: $2,510 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,099 · Consulting Fee: $2,250 · Food and Beverage: $1,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,098.86 |
| Consulting Fee | $2,250.00 |
| Food and Beverage | $1,726.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,113.85 | 2019-2025 | |
| Medical Device Business Services, INC. | $5,066.08 | 2021-2024 | Biolox Delta, Global, Inhance |
| Tricoast Surgical Solutions LLC | $3,278.40 | 2022-2025 | |
| Stryker Corporation | $1,217.42 | 2019 | |
| Depuy Synthes Sales INC. | $688.99 | 2019-2023 | Inhance |
| Southtech Orthopedics | $542.94 | 2020 | |
| Wright Medical Technology, INC. | $261.52 | 2019 | |
| Innovation Technologies INC | $212.49 | 2023-2024 | Irrisept |
| Linvatec Corporation | $147.71 | 2023 | Hercules Suture Anchor System, Quantum, In2bones USA |
| Dendreon Pharmaceuticals LLC | $127.50 | 2025 | Provenge |
| Exactech, INC. | $121.71 | 2023 | |
| Arthrosurface Incorporated | $95.34 | 2019 | |
| Axogen | $87.01 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Ethicon US, LLC | $67.78 | 2019-2025 | Vistaseal |
| Endo Pharmaceuticals INC. | $62.78 | 2022-2023 | Xiaflex |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53.69 | 2024 | Eterna |
| Kowa Pharmaceuticals America, INC. | $53.68 | 2022-2023 | Seglentis |
| Medartis INC. | $37.25 | 2019-2022 | |
| Anika Therapeutics, INC. | $33.73 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.03 | 2025 | |
| Merck Sharp & Dohme LLC | $27.91 | 2019-2023 | Bridion |
| Bioventus LLC | $27.02 | 2022 | |
| Integra Lifesciences Corporation | $25.96 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.27 | 2021 | |
| Covidien Lp | $20.12 | 2019 | |
| Treace Medical Concepts, INC. | $19.48 | 2024 | |
| La Jolla Pharmaceutical Company | $17.44 | 2024 | Xerava |
| Ermi LLC | $15.89 | 2019 | |
| Acell, INC. | $15.38 | 2019 | |
| Melinta Therapeutics, LLC | $14.76 | 2019 | |
| Medtronic, INC. | $11.69 | 2022 | |
| Cook Medical LLC | $11.36 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.